| Asthma and respiratory diseases | Lifetime | 38 | GB 10 | 99.85 |
| Histone Deacetylase Inhibitors Research | Lifetime | 19 | GB 1 | 99.72 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 58 | GB 13 | 99.72 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 38 | GB 4 | 99.62 |
| NF-κB Signaling Pathways | Lifetime | 21 | GB 1 | 99.67 |
| Pediatric health and respiratory diseases | Lifetime | 39 | GB 10 | 99.58 |
| IL-33, ST2, and ILC Pathways | Lifetime | 32 | GB 5 | 99.52 |
| Estrogen and related hormone effects | Lifetime | 154 | GB 12 | 99.29 |
| Neonatal Respiratory Health Research | Lifetime | 267 | GB 34 | 99.08 |
| Immune Response and Inflammation | Lifetime | 270 | GB 19 | 99.27 |
| Epigenetics and DNA Methylation | Lifetime | 369 | GB 34 | 98.99 |
| Respiratory and Cough-Related Research | Lifetime | 160 | GB 31 | 98.97 |
| COVID-19 Clinical Research Studies | Lifetime | 751 | GB 78 | 97.37 |
| Respiratory Support and Mechanisms | Lifetime | 599 | GB 50 | 98.43 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 284 | GB 21 | 97.26 |
| Peptidase Inhibition and Analysis | Lifetime | 827 | GB 53 | 97.40 |
| Protein Degradation and Inhibitors | Lifetime | 402 | GB 27 | 96.92 |
| Hydrogen's biological and therapeutic effects | Lifetime | 62 | GB 4 | 94.91 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 477 | GB 54 | 96.75 |
| Inflammatory mediators and NSAID effects | Lifetime | 984 | GB 88 | 95.23 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 808 | GB 59 | 91.04 |
| Delphi Technique in Research | Lifetime | 772 | GB 200 | 87.44 |
| Macrophage Migration Inhibitory Factor | Lifetime | 819 | GB 53 | 82.13 |
| Medical and Biological Ozone Research | Lifetime | 934 | GB 30 | 78.90 |
| Asthma and respiratory diseases | 2021-2025 | 104 | GB 14 | 98.93 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 169 | GB 28 | 97.52 |
| COVID-19 Clinical Research Studies | 2021-2025 | 973 | GB 106 | 96.14 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 87 | GB 9 | 94.30 |
| Neonatal Respiratory Health Research | 2021-2025 | 328 | GB 32 | 95.69 |
| Respiratory Support and Mechanisms | 2021-2025 | 956 | GB 70 | 90.79 |
| Respiratory and Cough-Related Research | 2021-2025 | 543 | GB 75 | 83.51 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 560 | GB 58 | 81.95 |
| Delphi Technique in Research | 2021-2025 | 442 | GB 120 | 77.13 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 616 | GB 33 | 74.61 |
| Inflammation biomarkers and pathways | 2021-2025 | 251 | GB 7 | 57.04 |
